JavaScript has been disabled within your browser, the content or the functionality of this web page can be limited or unavailable.

Skip to Content

UNC Health includes:

UNC Hospitals

UNC Children's

UNC Health Rex

UNC Health Lenoir

UNC Health Chatham

UNC Health Johnston

UNC Health Rockingham

UNC Health Nash

UNC Health Pardee

UNC Health Caldwell

UNC Health Wayne

Onslow Memorial Hospital

UNC Health Medical Group

UNC School of Medicine

UNC Health Southeastern

UNC Health Blue Ridge

UNC Health Appalachian
UNC School of Medicine
A detailed overview of your patient's medical record

Secure messaging with UNC Health Care providers regarding your patient's care

Access to scheduled appointments, medications, allergies and outpatient & inpatient notes (including admissions, discharges and emergency services)

Online referrals for outpatient and ancillary services

Access to historical WebCIS and Cerner information on your patients in addition to any new patient information

Helps with CMS Meaningful Use and patient-centered medical home efforts

Sign In
First Time User? Enroll now.
My UNC ChartMy Chart
Get Care Now

Effective Jan. 5, 2026: Temporary Age-Based Visitor Restrictions at UNC Health for all inpatient and waiting areas throughout its inpatient hospitals.

Published on April 27, 2020

SARS CoV-2 (COVID-19) Nucleocapsid Total Antibody

Tube Type = Gold Top

Tube Type

Test ID		LAB11462
EPIC Order		SARS CoV-2 Nucleocapsid, Total Antibody, Serum
CPT Code(s)		86769
Group/Individual Test		Individual
Laboratory		Core Referral Testing
Tube Station		30
Specimen	Routine: Micro:	Serum: 3 ml blood/gold SST tube 1.5 mL blood
Availability	Routine:	Reference Laboratory-Mayo Clinic Laboratories
	STAT:	N/A
Turnaround Time		3 Days
Reference Range	Normal:	See Separate Report.
Comments	This test provides qualitative detection of serum antibodies against the nucleocapsid protein of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), the causative agent of coronavirus disease 2019 (COVID-19). This test will not yield a positive result following vaccination against SARS-CoV-2. This test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. Fact sheets for this emergency use authorization (EUA) assay can be found at the following links: For healthcare providers: www.fda.gov/media/137603/download For patients: www.fda.gov/media/137604/download

Reviewed by J. Carr on December 08, 2025

UNC Hospitals
McLendon Clinical Laboratories
101 Manning Drive
Chapel Hill, NC 27514